Trials / Terminated
TerminatedNCT01699581
Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Greg Monohan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Nestle Impact has shown efficacy in multiple surgical trials in relation to improving hospital length of stay and infection rate. 1 dose of Nestle Impact Advanced Recovery will be taken orally three times a day beginning on the morning following stem cell transplant and will continue until the day of hospital discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nestle Impact Advanced Recovery | dose of Nestle Impact Advanced Recovery orally three times a day beginning on the morning following stem cell transplant and continued until the day of hospital discharge. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-06-01
- Completion
- 2015-10-01
- First posted
- 2012-10-03
- Last updated
- 2016-10-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01699581. Inclusion in this directory is not an endorsement.